Govern, validate, and scale your AI portfolio from target discovery to commercial execution. Ensure unshakeable FDA/EMA compliance while accelerating pipeline speed.
Drug Discovery Pipeline — GxP Validated
Target ID → Trial
Pipeline Telemetry
Target
Validate
Preclin
Trial
Automated Audit Trail
✓ Model revalidation — 14:02 UTC
✓ Drift check passed — 14:03 UTC
✓ Audit log sealed — 14:03 UTC
FDA and EMA tightening rules around algorithmic transparency. A single unvalidated model can derail approval timelines.
Millions invested in generative biology and target discovery models without a standardized framework to scale them to production.
Predictive models for patient enrollment and site selection degrading over time, leading to costly trial delays and invalid data.
Integrate
Connect models seamlessly into EDC systems, data lakes, and QMS platforms. Deploy on-premise, in sovereign clouds, or hybrid environments.
Monitor
Continuously monitor target identification models, LLMs, and trial prediction engines for data shift and hallucination.
Protect
Maintain immutable, audit-ready logs for regulatory submission. Enforce strict data privacy and model governance automatically.
Faster to trial
Validate and monitor predictive biology models to bring candidate targets to trial faster.
Real-time RWE
De-risk enrollment predictions, site selection, and Real-World Evidence (RWE) models in real time.
Audit-ready
Guarantee full compliance, prevent costly deployment delays, and measure commercial model impact.
Centralize visibility over all proprietary and vendor models across global business units.
Speak with our life sciences technical team to learn how we de-risk enterprise AI assets.